Design and synthesis of piperazine-indole p38α MAP kinase inhibitors with improved pharmacokinetic profiles

SAR studies of the p38α MAP kinase inhibitor SCIO-469 focused on maintaining activity while improving pharmacokinetic properties. Advantages were noted for compounds bearing substituents on the benzylic methylene carbon. Derivatives of the 4-fluorobenzyl dimethylpiperazine-indole class of p38α MAP k...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2010-02, Vol.20 (3), p.828-831
Hauptverfasser: Tan, Xuefei, Tester, Richland W., Luedtke, Gregory R., Chakravarty, Sarvajit, Mavunkel, Babu J., Perumattam, John J., Lu, Qing, Nashashibi, Imad, Jung, Joon, Hu, Jie, Liclican, Albert, Almirez, Ramona, Tabora, Jocelyn, Tran, Vinh, Laney, Maureen, Levy, Daniel E., Dugar, Sundeep
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:SAR studies of the p38α MAP kinase inhibitor SCIO-469 focused on maintaining activity while improving pharmacokinetic properties. Advantages were noted for compounds bearing substituents on the benzylic methylene carbon. Derivatives of the 4-fluorobenzyl dimethylpiperazine-indole class of p38α MAP kinase inhibitors are described. Biological evaluation of these compounds focused on maintaining activity while improving pharmacokinetic (PK) properties. Improved properties were observed for structures bearing substitutions on the benzylic methylene.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2009.12.091